1. Home
  2. AVTR vs CYTK Comparison

AVTR vs CYTK Comparison

Compare AVTR & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avantor Inc.

AVTR

Avantor Inc.

N/A

Current Price

$15.03

Market Cap

10.5B

Sector

Industrials

ML Signal

N/A

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$65.62

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVTR
CYTK
Founded
1904
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
10.7B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
AVTR
CYTK
Price
$15.03
$65.62
Analyst Decision
Hold
Buy
Analyst Count
17
22
Target Price
$14.66
★ $109.90
AVG Volume (30 Days)
★ 7.9M
1.5M
Earning Date
10-28-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.06
N/A
Revenue
★ $6,552,200,000.00
$13,368,000.00
Revenue This Year
$0.63
$70.12
Revenue Next Year
$2.36
$183.63
P/E Ratio
$254.00
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$7.27
$54.30
52 Week High
$16.05
$88.31

Technical Indicators

Market Signals
Indicator
AVTR
CYTK
Relative Strength Index (RSI) 54.78 35.28
Support Level $13.20 $59.05
Resistance Level $16.05 $67.04
Average True Range (ATR) 0.44 2.04
MACD -0.10 -0.10
Stochastic Oscillator 35.47 18.85

Price Performance

Historical Comparison
AVTR
CYTK

About AVTR Avantor Inc.

Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: